...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: For what it’s worth

By the way, nice find jbuffett62!

tada

 

Share
New Message
Please login to post a reply